Inhibition of mTOR by rapamycin in the amygdala or hippocampus impairs formation and reconsolidation of inhibitory avoidance memory

Neurobiol Learn Mem. 2012 Jan;97(1):105-12. doi: 10.1016/j.nlm.2011.10.002. Epub 2011 Oct 19.

Abstract

Mammalian target of rapamycin (mTOR), a central regulator of protein synthesis in neurons, has been implicated in synaptic plasticity and memory. Here we show that mTOR inhibition by rapamycin in the basolateral amygdala (BLA) or dorsal hippocampus (DH) impairs both formation and reconsolidation of memory for inhibitory avoidance (IA) in rats. Male Wistar rats received bilateral infusions of vehicle or rapamycin into the BLA or DH before or after IA training or retrieval. Memory retention was tested at different time points after drug infusion. Rapamycin impaired long-term IA retention when given before or immediately after training or retrieval into the BLA. When infused into the DH, rapamycin produced memory impairment when given before training or immediately after retrieval. The impairing effects of post-retrieval rapamycin required memory retrieval and were not reversed by a reminder shock. The results provide the first evidence that mTOR in the BLA and DH might play a role in IA memory reconsolidation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amygdala / drug effects*
  • Animals
  • Avoidance Learning / drug effects*
  • Electroshock
  • Hippocampus / drug effects*
  • Male
  • Memory / drug effects*
  • Neurons / drug effects
  • Rats
  • Rats, Wistar
  • Retention, Psychology / drug effects
  • Retention, Psychology / physiology
  • Sirolimus / pharmacology*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*

Substances

  • TOR Serine-Threonine Kinases
  • Sirolimus